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ORIGINAL ARTICLEDifferences in Staining for Neutrophil
Elastase and its Controlling Inhibitor SLPI
Reveal Heterogeneity among Neutrophils
in Psoriasis
Joanna Skrzeczynska-Moncznik1, Katarzyna Zabieglo1, Oktawia Osiecka1, Agnieszka Morytko1,
Piotr Brzoza1, Lukasz Drozdz1, Monika Kapinska-Mrowiecka2, Brice Korkmaz3, Maciej Pastuszczak4,5,
Joanna Kosalka-Wegiel5, Jacek Musial5 and Joanna Cichy1Neutrophils are broadly classified into conventional neutrophils (PMNs) and low-density granulocytes (LDGs).
LDGs are better than PMNs at generating neutrophil extracellular traps (NETs), which may contribute to the
pathology of autoimmune diseases. We hypothesized that LDGs and PMNs differ in their levels of unrestrained
NE that supports NET generation. Here, we show that individuals with psoriasis contain elevated levels of LDGs
and that in contrast to PMNs, the LDGs display higher staining for NE and lower staining for its inhibitor SLPI.
The heterogeneity between blood-derived LDGs and PMNs was somewhat reminiscent of the differences in the
NE and SLPI staining patterns observed in psoriasis skin-infiltrating neutrophils. Distinctive staining for NE and
SLPI in LDGs and PMNs did not result from differences in their protein levels nor manifested in higher total
proteolytic activity of NE in LDGs; rather, it likely depended on different cytosolic sequestration of these
proteins. The disparate profile of NE and SLPI in LDGs and PMNs coincided with altered migratory responses of
these cells to cutaneous chemoattractants. Collectively, differential NE and SLPI staining identifies common
attributes of both circulating and skin-infiltrating neutrophils, which may guide neutrophil migration to distinct
skin regions and determine the localization of LDGs-mediated cutaneous pathology.
Journal of Investigative Dermatology (2020) 140, 1371e1378; doi:10.1016/j.jid.2019.12.015INTRODUCTION
The infiltration of the skin by neutrophils is one of the hallmarks
of psoriasis. Neutrophils can contribute to skin inflammation via
different means: as a source of IL-17 (Lin et al., 2011), through
the activation of the IL-36 family of cytokines by proteolytic
processing (Henry et al., 2016), via the release of neutrophil
extracellular traps (NETs) and stimulation of plasmacytoid den-
dritic cells (Lande et al., 2011; Skrzeczynska-Moncznik et al.,
2012) or through NETs-mediated induction and/or expansion of
memory T helper type 17 cells (Lambert et al., 2019).
NETs are DNA deposits decorated by nuclear and
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decondensation (Papayannopoulos et al., 2010). The pro-
teolytic activity of NE is controlled by endogenous inhibitors,
such as SLPI, (Majchrzak-Gorecka et al., 2016). SLPI is the
major inhibitor of NE present in the neutrophil cytosol and
blunts both histone processing and NET expulsion into the
extracellular space (Zabieglo et al., 2015).
At least two populations of circulating neutrophils have
been described in humans: low-density granulocytes (LDGs)
and conventional polymorphonuclear neutrophils (PMNs).
Whereas PMNs sediment together with red blood cells during
density gradient separations, LDGs localize to the peripheral
blood mononuclear cell (PBMC) fraction (Carmona-Rivera
and Kaplan, 2013). LDGs were first described in patients
with systemic lupus erythematosus (SLE), where they were
found to be enriched in transcripts that encode proteins found
in the early stages of neutrophil differentiation (Bennett et al.,
2003; Villanueva et al., 2011) and to contain non-lobulated
and hyposegmented nuclei, unlike PMNs (Carmona-Rivera
and Kaplan, 2013). These findings suggest that LDGs are
newly emergent neutrophils that are mobilized from the bone
marrow to circulation before they are terminally
differentiated. However, the immature phenotype of LDGs is
not consistent with the cell surface molecule expression
on these cells, which is more typical of fully-developed
neutrophils (Carmona-Rivera and Kaplan, 2013). The lower
buoyancy of LDGs may also be the result of cell activation






































Figure 1. Neutrophils infiltrating the
skin of patients with psoriasis differ in
their pattern of NE and SLPI staining.
Fluorescence microscopy images of
lesional skin stained for NE (red), SLPI
(green), and DNA (blue). Indicated skin
regions (#, ##, ###) represent
epidermis, upper dermis, and lower
dermis, respectively. (a) An overlay or
single channel images from one donor.
(b) Analysis of the distribution of
neutrophils in regions “# - ###” based
on the indicated NE and SLPI staining
pattern, n ¼ 6. For each patient, at least
six different high-power fields spanning
the epidermis and dermis were
analyzed. Each data point represents
one experiment, and bars indicate the
mean value  standard deviation in
each group. ***P < 0.001, *P < 0.05
by an analysis of variance followed by a
Tukey post hoc test. (c) Overlay image
from a second donor with enlarged
regions ## and ### demonstrating
neutrophils that differ in staining for NE
and SLPI. Neutrophils that are positive
primarily for NE (NEhi) are shown by
asterisks. Arrowheads highlight
neutrophils that stained strongly for
both NE and SLPI (SLPI/NE). Bar ¼100
mm (a, c left panel) or 10 mm (c middle
and right panels).
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1372to degranulation (Hacbarth and Kajdacsy-Balla, 1986) and/or
other alterations, such as an increase in cell volume (Sagiv
et al., 2015). LDGs may represent a heterologous
population of both immature and mature (either activated,
aged, or primed) neutrophils (Nicolás-Ávila et al., 2017).
Patients with autoinflammatory diseases, such as SLE and
psoriasis, upregulate the levels of circulating LDGs; this is
notable, as LDGs counts are associated with the severity of
psoriasis (Teague et al., 2019). Moreover, in autoimmune
patients, LDGs display pro-inflammatory potential, such as
toxicity to endothelial cells and a heightened ability to syn-
thesize tumor necrosis factor-a or IFNs (Denny et al., 2010).
Although these data suggest that LDGs might promote
autoimmune conditions, studies of these cells are hampered
by the lack of specific phenotypic and functional markers.
Therefore, a better knowledge of neutrophil heterogeneity
may provide important insights into the functional diversity of
these cells.
RESULTS
Neutrophils from psoriasis patients are phenotypically and
functionally diverse
To determine whether the neutrophils infiltrating skin of
psoriasis patients differ in immunoreactivity for NE and/or
SLPI, we stained skin samples of these patients with anti-NE
and anti-SLPI antibodies (Abs), followed by fluorescence
microscopy. Skin samples derived from the same donors
exhibited different staining patterns, manifested by NE and
SLPI costaining (SLPI/NE), or staining predominantly for NE
(NEhi) (Figure 1aec). Whereas neutrophils that costained forJournal of Investigative Dermatology (2020), Volume 140NE and SLPI were the most abundant in the epidermis,
neutrophils with stronger staining for NE were mostly seen in
deeper skin regions (Figure 1b and c). Thus, neutrophils that
infiltrate diverse skin niches are heterogenous in respect to
NE and SLPI staining.
Different populations of circulating neutrophils may
account for neutrophil heterogeneity in psoriasis skin. To
determine whether LDGs and PMNs differ in NE and/or
SLPI staining, we next analyzed the frequency and
phenotype of these two populations isolated from the pe-
ripheral blood of psoriasis patients and healthy individuals
by flow cytometry. SLE patients served as the positive
control. In agreement with previous reports (Lin et al.,
2011; Teague et al., 2019), we found higher levels of
LDGs in PBMCs from psoriasis and SLE patients than those
from heathy individuals. PBMCs from psoriasis donors
showed 5-fold higher levels of LDGs on average, which
constituted as high as 14e18% of the total PBMCs in some
patients (Figure 2a and b).
Several surface markers have been previously studied
with respect to the status of LDGs. These include markers
of mature neutrophils, such as CD10, or those of activated
neutrophils that upregulate CD66b and CD11b and
downregulate CD62L surface levels (Scapini et al., 2016).
We found that LDGs from psoriasis donors did not exhibit
significant alterations in the surface expression of CD10
and CD11b but expressed significantly higher levels of
CD15 and CD66b and lower levels of CD62L, in contrast
to PMNs (Figure 2c). The profile was consistent with a
mature neutrophil phenotype and indicated some level of


































































Figure 2. Circulating LDGs are present at higher frequencies in psoriasis compared with normal donors and have the phenotypic and functional features of
matured, activated, and pro-inflammatory neutrophils. PBMCs were isolated from the blood of indicated donors and stained for LDGs and monocytes using
anti-CD15 and anti-CD14 mAbs. The cells were then analyzed by flow cytometry. (a) Representative flow cytometry plots of the LDGs are shown. (b) Data are
shown as the percentage of LDGs among PBMC. Lines indicate the mean value for each data set. n ¼ 45, 70, and 11 for healthy, psoriasis, and SLE donors,
respectively. ***P < 0.001; Kruskal-Wallis ANOVA, Dunn post hoc test. (c) Expression of the indicated molecules was evaluated on LDGs and PMNs from
psoriasis patients by flow cytometry. Data are shown as the MFI among indicated antigen expression in autologous pairs of LDGs versus PMNs. Lines indicate
the mean value for each data set; n ¼ 10 donors in each group. ***P < 0.001, ****P < 0.0001; two-way matched ANOVA; Sidak post hoc test. (d) Cell-sorted
PMNs and LDGs were harvested on poly-L-lysine coated slides and incubated for 3 hours. Cells were then stained for NE (red), counterstained with Hoechst to
detect DNA (blue), and examined by fluorescence microscopy. One representative dataset of at least three experiments is shown. Bar ¼ 10 mm. ANOVA,
analysis of variance; LDG, low-density granulocyte; MFI, mean fluorescence intensity; PBMC, peripheral blood mononuclear cell; PMN, polymorphonuclear
neutrophil; SLE, systemic lupus erythematosus.
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et al., 2019). Likewise, fluorescence microscopy revealed
that a majority of LDGs possessed segmented nuclei,
with a minority possessing ovoid nuclei (Figure 3c), sug-
gesting a primarily mature status of these cells in psoriasis
patients.
To assess the functional capacity of LDGs relative to
autologous PMNs from psoriasis patients, both cell pop-
ulations were tested for NET formation. In agreement with
previous reports (Naik et al., 2015; Teague et al., 2019),
LDGs displayed a higher ability than PMNs to spontaneously
form NETs (Figure 2d and Supplementary Figure S1), indic-
ative of a potentially augmented pathogenic capacity of
LDGs compared with their PMN counterparts.
LDGs and PMNs exhibit different staining for NE and SLPI
but are roughly equal in NE and SLPI protein levels and NE
proteolytic activity
By flow cytometry, we next analyzed whether LDGs and
PMNs differ in their levels of NE and SLPI, focusing on both
cell surface and intracellular NE and SLPI. A small fraction of
fixed LDGs showed a differential surface presentation of NE
and SLPI compared with fixed autologous PMNs (Figure 3a).
However, when the cells were fixed and then permeabilizedto target the intracellular NE and SLPI, the marked difference
in the staining for NE and SLPI between a majority of LDGs
and autologous PMNs was observed (Figure 3a). Thus, in
subsequent experiments, we stained the permeabilized cells
to target both cell surface and intracellular NE and SLPI. In
addition to flow cytometry, immunohistochemistry also
revealed that the LDGs exhibit much stronger staining for NE
and lesser staining for SLPI, compared with the autologous
PMNs (Figure 3b and c, respectively). Higher and weaker
immunoreactivity to NE and SLPI were apparent when the
LDGs were stained together with other cells in the PBMC
fraction (Figure 3c) and after they were purified by cell sorting
(Figure 3d). Whereas PMNs displayed NE and SLPI staining
that was mostly restricted to a granular pattern, autologous
LDGs showed more dispersed NE (Figure 3e). Targeting either
NE or SLPI with three different Abs followed by flow
cytometry analysis demonstrated similar staining patterns
between autologous LDGs and PMNs, suggesting that
these differences are independent of the staining Abs
(Supplementary Figure S2).
We next quantified NE in lysates of PMNs and LDGs iso-
lated from psoriasis patients by ELISA. As a control, we used
autologous monocytes that do not express NE (Fouret et al.,







































































Figure 3. LDGs have greater immunoreactivity for NE and weaker for SLPI relative to the autologous PMNs. PBMCs and PMNs were isolated from blood and
stained for LDGs and PMNs using anti-CD15 and anti-CD14 mAbs. (a) Expression of NE or SLPI was evaluated on live (upper panel), fixed (middle panel), or
fixed and permeabilized (lower panel) LDGs (gray) and PMNs (black). Representative flow cytometry histogram plots of psoriasis patients are shown, n ¼ 3.
Open histograms indicate the respective staining controls. (b) Expression of NE or SLPI was evaluated on permeabilized LDGs and PMNs of indicated donors
by flow cytometry. Lines indicate the mean value for each data set. Statistically significant differences between PMN and LDGs are indicated by asterisks
(**P < 0.01, *P < 0.05; Kruskal-Wallis analysis of variance, Dunn post hoc test). (c) Expression of NE and SLPI on PMNs and PBMCs from psoriasis donors was
analyzed by immunohistochemistry, n ¼ 5. (d) Expression of NE and SLPI on cell-sorted PMNs and LDGs from psoriasis donors was analyzed by fluorescence
microscopy, n¼ 3. (e) Confocal microscopy images of NE and SLPI in PMNs and LDGs from a healthy donor. PMNs and LDGs were analyzed under the different
acquisition settings (different exposure time) to best visualize the distribution of NE and SLPI. n ¼ 3. Bar ¼ 10 mm. LDG, low-density granulocyte; MFI, mean
fluorescence intensity; PBMC, peripheral blood mononuclear cell; PMN, polymorphonuclear neutrophil; SLE, systemic lupus erythematosus.
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1374et al., 2016). There were no notable differences between
autologous LDGs and PMNs in the total NE protein content
(Figure 4a). Although SLPI levels were variable in leukocytes
from different donors, they were likewise found to be com-
parable in autologous PMNs and LDGs on average
(Figure 4b). Overall, these data suggest that the stronger
staining of LDGs for NE and weaker staining for SLPI, in
comparison to PMNs, cannot be attributed to the difference
in cellular content of NE and SLPI.
Using an activity-based spectrometric assay, we next
determined the enzymatic potential of NE in lysates of LDGs
and PMNs sorted from psoriasis patients. On average, the
LDGs and PMNs were found to contain similar levels of
catalytically active NE, as indicated by the hydrolysis of a
widely used chromogenic, synthetic peptide substrate, MeO-
SucAAPVpNA. However, a trend toward reduced NE activity
in LDGs (compared with autologous PMNs) was observed
(Figure 4c). Similar results were obtained when the NE ac-
tivity was measured in LDG and PMN lysates, using an en-
ergy transfer substrate (Abz-APEEIMRRQ-EDDnp), which is
highly specific for NE (Figure 4d) (Korkmaz et al., 2008).
These data indicate that the total levels of active NE are
roughly similar in LDGs and PMNs.Journal of Investigative Dermatology (2020), Volume 140Extra NE and SLPI epitopes in PMNs and LDGs are revealed
in some individuals following the disruption of actin
cytoskeleton dynamics
The staining heterogeneity for NE and SLPI observed could
be caused by a difference in the accessibility of these an-
tigens for detection with Abs. In resting PMNs, NE and SLPI
are stored in primary and secondary granules, respectively.
However, following neutrophil activation that results in
NET formation, NE translocates to the nucleus, and SLPI
likely follows (Zabieglo et al., 2015). Since interactions
with the cytoskeleton may regulate NE and/or SLPI acces-
sibility, we treated the PMNs and LDGs with latrunculin A
or wiskostatin to inhibit actin polymerization. The treat-
ment of PMNs resulted in much stronger staining for NE
(Figure 5a) in approximately 67% of the donors, whereas
the staining remained at a similar level in the other 33%.
Moreover, in some donors, the treatment facilitated the
translocation of NE to the nucleus (Figure 5b). In these
cells, SLPI was not detectable (Figure 5b). Likewise, in
approximately 67% of the donors, the LDGs showed
reduced staining for NE following treatment with latrun-
culin; a stronger staining for SLPI was observed following





































































Figure 4. Psoriasis LDGs and PMNs have similar protein levels of NE and
SLPI and do not differ significantly in their NE activity. PMNs (CD15þ,
CD14- ) were sorted from PMN fractions, whereas LDGs (CD15þ, CD14- )
and monocytes (CD14þ, CD15- ) were sorted from the PBMC fraction of
psoriasis patients. (a) NE and (b) SLPI protein levels were assessed in the cell
lysates by ELISA. Lines indicate the mean value for each data set, n ¼ 12. (c)
NE enzymatic activity in cell lysates was measured by a MeO-SucAAPVpNA
hydrolysis assay, n ¼ 17, (d) or by fluorimetry, using the fluorescence
resonance energy transfer substrate, Abz-APEEIMRRQ-EDDnp, n ¼ 6. Lines
indicate the mean value for each data set. Each patient is marked by a
different symbol in each panel and across panels. AU, absorbance units;
FRET, fluorescence resonance energy transfer; LDG, low-density granulocyte;













Figure 5. Disruption of the actin cytoskeleton alters the immunoreactivity
for NE and SLPI in neutrophils and facilitates the translocation of NE to the
nucleus in PMNs. (a) Circulating PMNs and PBMCs from a healthy donor and
(b) negatively sorted PMNs and LDGs from a psoriasis patient were treated
with latrunculin A to disrupt the actin cytoskeleton. Control cells were treated
with vehicle (-). (a) Cells were then stained with phalloidin to visualize F-actin
(green) and for NE (red), (b) or for NE (red) and SLPI (green). Cells were
examined by fluorescence microscopy. Data are representative of four
independent experiments. LDG, low-density granulocyte; PBMC, peripheral
blood mononuclear cell; PMN, polymorphonuclear neutrophil.
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Thus, the apparent presence of NE or SLPI in both
neutrophil populations could be unmasked by forced
changes in cytoskeleton dynamics.
We next asked if the inhibition of actin polymerization in
PMNs results in PMNs that functionally resemble LDGs. We
tested this using NET formation as a readout, because the
LDGs of both psoriasis and healthy donors (Figure 2 and
Supplemetary Figure S1) spontaneously form more NETs. On
average, latrunculin- or wiskostatin-treated PMNs appeared
to increase their tendency to release NETs, in line with a
previous report (Cervantes-Luevano et al., 2018).
LDGs and PMNs differ in their chemotactic attributes
Cytoskeleton remodeling is critically involved in cell
migration. LDGs and PMNs may use the interaction be-
tween actin cytoskeleton and NE and/or SLPI to differen-
tially control cell movement. Therefore, we next
determined whether these neutrophil populations exhibit
differences in chemotactic response. To mimic the skin
environment associated with neutrophil recruitment to
inflamed skin, we used skin extracts prepared from bi-
opsies of lesional skin of psoriasis patients. The chemo-
attractant N-formylmethionyl-leucyl-phenylalanine (fMLP)
and the psoriasis-associated chemokine CXCL1 (Li et al.,
2014) were used as positive controls, whereas chemo-
taxis medium was used as a negative control. When
autologous PBMCs and PMNs isolated from the blood of
psoriasis donors were assessed in a standard Transwell
chemotaxis assay, the LDGs showed a trend for a better
chemotactic response to the skin extracts compared withthe PMNs. In contrast, fMLP appeared to attract a higher
number of PMNs than LDGs (Supplementary Figure S3).
Since other cells present in PBMC fractions might selec-
tively influence the chemotactic response of LDGs, we
next labeled PMNs with carboxyfluorescein succinimidly
ester, and then we mixed carboxyfluorescein succinimidly
ester-labeled PMNs with PBMCs, followed by the chemo-
taxis assay. Unlabeled PMNs and carboxyfluorescein suc-
cinimidly ester-labeled PMNs showed a similar relative
response either to skin extracts or fMLP; the combined
chemotactic response of both unlabeled and carboxy-
fluorescein succinimidly ester-labeled PMNs and LDGs is
shown in Figure 6a. Overall, the LDGs were found to
respond better to skin extracts but migrate significantly less
efficiently to fMLP and CXCL1 when compared with the
PMNs. These experiments confirmed that the difference in
migration is mainly a result of an intrinsic feature of these
neutrophil populations.
The inhibition of NE activity by synthetic inhibitor
GW311616A, which penetrates cell membranes and thus
targets intracellular NE, reduced the migration index of PMNs
and LDGs by 30e40% on average (Supplementary
Figure S4). These data suggest that the migratory capacity of
PMNs and LDGs depends on active NE. Since the LDGs from
different donors differed markedly in their migratory poten-











































































Figure 6. LDGs and PMNs from psoriasis
donors differ in their chemotactic response.
(a) PMNs and LDGs (CD15þ PBMCs)
migration to the fMLP, CXCL1, or psoriasis
skin extracts was assessed by an in vitro
Transwell chemotaxis assay. Migration to
media only is shown as negative control.
n ¼ 19 donors. Data points mainly represent
the values of two samples from each donor:
For PMNs, CFSE-unlabeled, and CFSE-labeled
PMNs that were mixed with PBMCs; for
LDGs, PBMCs, and PBMCs that were mixed
with CFSE-labeled PMNs. The mean value in
each group is shown. Statistically significant
differences between the groups are indicated
by asterisks (*P < 0.05, **P < 0.01, ***P <
0.001, ****P < 0.0001; two-way Kruskal-
Wallis analysis of variance, Dunn post hoc
test). (b) Chemotaxis of autologous LDGs and
PMNs to fMLP and skin extracts is shown as a
function of the NE to SLPI index in LDGs
normalized to the NE to SLPI index in PMNs.
CFSE, carboxyfluorescein succinimidly ester;
fMLP, N-formylmethionyl-leucyl-
phenylalanine; LDG, low-density
granulocyte; PBMC, peripheral blood
mononuclear cell; PMN, polymorphonuclear
neutrophil.
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analysis, the chemotaxis index of autologous PMNs and
LDGs is shown as a function of the NE/SLPI staining ratio in
the skin extracts-stimulated and fMLP-stimulated neutrophils
(Figure 6b). LDGs displayed diverse NE/SLPI ratios, ranging
from 2-fold to 16-fold above the autologous PMNs. The LDGs
consistently migrated less efficiently to fMLP, despite the
difference in the NE/SLPI ratio. However, the migration to
skin extracts revealed two migration patterns of the LDGs in
relation to NE/SLPI index. The LDGs that displayed the lowest
NE/SLPI ratio (2e5) appeared to respond better, whereas
those with higher NE/SLPI ratios (>5 up to 16) migrated
less efficiently to skin extracts compared with autologous
PMNs.
DISCUSSION
Here, we report the previously uncharacterized differences in
staining for NE and SLPI in LDGs in comparison to autolo-
gous PMNs (Figure 3). Although this phenotype was not
unique to individuals suffering from psoriasis, is it likely to
primarily have a functional impact on patients with auto-
inflammatory diseases, such as psoriasis, which are charac-
terized by a high prevalence of LDGs.
The augmented and reduced staining for NE and SLPI in
the LDGs suggested that frequent NETs formation by LDGs
might result from elevated NE activity that has not been
fully inhibited by SLPI. We found that neither the quantity
nor bioactivity of total NE appear to be significantly altered
in LDGs. However, cell lysis, which was required for the
measurement of intracellular NE activity, may disrupt the
interaction of NE with its intracellular partners and influ-
ence its functional state. Because SLPI is a reversible in-
hibitor of NE, it may be particularly well-suited to
dynamically control NE activity. However, the transientJournal of Investigative Dermatology (2020), Volume 140nature of interactions between NE and SLPI can be easily
reversed by cell lysis conditions.
Differential staining for NE and SLPI in LDGs and PMNs
was mainly localized in the cytoplasm (Figure 3). As such,
the data suggested that the partial release of NE to the
cytosol, with possible binding to the cytoskeleton and/or
other cytosol components, may be responsible for the dif-
ferences in the NE staining between LDGs and PMNs. For
example, the localized enrichment of NE on the cytoskel-
eton and/or better availability of the NE immunoreactive
epitopes could be responsible for the stronger staining of
LDGs for NE. Our staining data support this scenario, since
in contrast to PMNs, the LDGs exhibited more dispersed NE
staining patterns in the cytoplasm, suggesting some release
of granule content. The SLPI’s level of detection inversely
correlated with NE in the neutrophil populations. The LDGs
may be more restricted than PMNs in mobilizing SLPI from
secondary granules, resulting in a distinct level or order of
SLPI presentation to cytosolic substrates and less effective
control of the NE activity. This is in line with the appearance
of additional NE and SLPI epitopes in PMNs and LDGs of
some patients as a result of the forced changes in actin
cytoskeleton dynamics.
With respect to the NE and/or SLPI staining, skin-
infiltrating neutrophils overlapped to some extent with the
circulating PMNs and/or LDGs. Moreover, in the in vitro
chemotaxis assay, the LDGs showed an elevated tendency
to migrate to psoriasis skin extracts on average, whereas the
PMNs exhibited significantly more robust migration to fMLP
and CXCL1 (Figure 6a). These data suggest that both
neutrophil populations are likely to be recruited into the
inflamed skin but possibly localized to different skin re-
gions, owing to a differential migratory response. This would
be consistent with the segregation of neutrophils that exhibit
J Skrzeczynska-Moncznik et al.
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niches (Figure 1). For example, fMLP attracted significantly
more PMNs than LDGs, despite comparable levels of cell
surface fMLP receptors in PMNs and LDGs (Figures 6 and 2,
respectively). PMNs, by following the gradient of peptides
with formyl methionine (which mimics bacterial peptides),
are more likely to localize to upper skin regions where
neutrophils may acquire bacteria or bacterial products
coming from the skin surface (Kwiecien et al., 2019).
However, it is also possible that neutrophils in the skin
differentially employ active NE to migrate and localize to
different skin niches, irrespective of their LDGs and/or
PMNs features.
Cytosolic NE was previously proposed to regulate neutro-
phil migration. In these studies, NE interference with actin
dynamics was suggested to disable the cell movement and
confine “NETting” neutrophils to the NET trigger site (Metzler
et al., 2014). Our data suggest that a higher cytosolic content
of NE, as seen in LDGs compared with autologous PMNs,
does not necessarily result in neutrophil immobilization, as
some LDGs were well-fitted to migrate to psoriasis skin
extracts. However, this may depend on the level of unre-
strained NE in the cytosol, as the high NE to SLPI index in
LDGs appeared to render these cells less able to migrate to
both fMLP and skin extracts (Figure 6).
The translocation of NE from the granules to the cytosol
can occur in response to neutrophil activation, whereas in
LDGs this may be a result of leaky primary granules at steady
state. This would be reminiscent of NE translocation to the
cytosol in aging neutrophils, which use NE to cleave gas-
dermin D and expedite neutrophil death (Kambara et al.,
2018). Thus, the presence of NE in the cytosol appears to
be a common feature of different functional states, leading to
neutrophil migration, immobilization, or death, with the type
of neutrophil inducer likely evoking a different response.
However, the permanent localization of NE in the cytosol
may endow LDGs with some pathogenic features, such as the
ability to respond in a less-controlled manner or with a lower
threshold to different stimuli.
In summary, the staining for NE and SLPI revealed het-
erogeneity among either skin-infiltrating or circulating neu-
trophils in psoriasis patients. The difference is likely owing to
higher and lower cytosolic content of NE and SLPI, respec-
tively, and/or different arrangement of these molecules in the
cytoplasm in LDGs compared with PMNs. LDGs and PMNs
also differ in their chemotactic responses. Taken together,
these results are consistent with a model in which cytosol-
exposed NE, not fully inhibited by SLPI, contributes to
distinct functional and migratory behavior of LDGs in com-
parison to the PMNs. Their capacity to differentially respond
to chemotaxis signals impacts the distribution of these cells in
the skin, allowing the LDGs and PMNs to be triggered by
distinct signals. LDGs respond in an exaggerated manner to
cutaneous stimuli, notably by an augmented release of NETs,
leading to skin pathology.
MATERIALS AND METHODS
Human samples
Human samples were collected from individuals who were fully
informed and had consented (written consent was obtained frompatients), and human studies were approved by the Jagiellonian
University Institutional Bioethics Committee. In total, 116 psoriasis
patients (age 38.1  12.8; male:female 72:44), 12 SLE patients (age
40.82  14, male:female 2:10), and 63 healthy individuals (age 31.7
 7.7; male:female 27:36 ) were enrolled in the study. The severity
of the psoriatic skin lesions was assessed according to the Psoriasis
Area Severity Index score (minimum, 0 points; maximum, 72 points)
and ranged from 1.9 to 62 (mean  standard deviation: 16.4  9.7).
The SLE disease activity was assessed by the SLE disease activity
index 2000 (Gladman et al., 2002).
Isolation of the LDGs and PMNs
Blood was collected into sodium citrate collection tubes and sub-
jected to the isolation of PMNs and LDGs within 1.5 hours of draw.
PBMCs and PMNs were isolated by a density gradient 1,077 g/ml
centrifugation using Pancoll (PANBiotech, Aidenbach, Germany).
LDGs, identified as CD15þ and CD14, were purified from the
PBMCs by cell sorting (MoFlowTMXDP, Beckman Coulter, Brea,
CA). Alternatively, LDGs were enriched by negative sorting using an
EasySep Human Neutrophil Enrichment Kit (STEMCELL Technolo-
gies, Vancouver, Canada). The purity of the cell- and magnetically-
sorted LDGs was typically around 90% and 50%, respectively.
PMNs were recovered from the corresponding erythrocyte frac-
tion of the Pancoll gradient as previously described (Skrzeczynska-
Moncznik et al., 2012). Where indicated, PMNs were further
purified by cell sorting using mAbs directed against CD14 and
CD15. The PMNs were routinely > 98% pure.
Flow cytometry
For the staining for NE and SLPI, the PMNs and PBMCs were first fixed
with 3.7% formaldehyde and permeabilized with 0.1% saponin in
phosphate buffered saline. The cells were incubated with primary
antibodies—polyclonal rabbit-anti-NE IgG (Athens Research and
Technology, Athens, GA) and/or monoclonal-biotin-mouse-anti-SLPI
(Abcam, Cambridge, United Kingdom) followed by secondary
antibodies; allophycocyanin-F(ab)2 goat-antirabbit IgG (Jackson
Immunoresearch, West Grove, PA) and phycoerythrin- or
allophycocyanin-streptavidin (eBioscience, San Diego, CA or BD
Pharmingen, San Jose, CA). Where indicated, the cells were stained
without the fixation or permeabilization step. The same primary Abs
for NE and SLPI were used across all the assays, unless otherwise
indicated. Flow cytometry was performed on an LSRII (BD Bio-
sciences, San Jose, CA), and the data were analyzed using the DIVA
and FCS Express software.
Immunohistochemistry
Frozen 6-mm sections were prepared from skin biopsies and stained as
previously described (Zabieglo et al., 2015). Purified PMNs, LDGs, or
PBMCs were seeded on poly-L-lysine coated slides (2e5  105 cells
per coverslip) and incubated at 37 C, 5% carbon dioxide for 30
minutes in serum-free RPMI. When indicated, the cells were incu-
bated for 3 hours to assess their ability to form NETs or treated with 1
mM latrunculin A (Invitrogen, Carlsbad, CA) or 100 nM wiskostatin
(Sigma-Aldrich, St. Louis, MO) for 30 minutes. The cells were then
fixed with 3.7% formaldehyde, treated with 0.1% saponin in phos-
phate buffered saline, and stained for NE, SLPI, and DNA (Zabieglo
et al., 2015). For cytoskeleton detection, the cells were per-
meabilized with 1% Triton X100 (ICN, Costa Mesa, CA) and stained
with phalloidin-AlexaFluor488 (Invitrogen, Carlsbad, CA) to visualize
actin. Images were captured with a fully motorized fluorescence orwww.jidonline.org 1377
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NIS elements software (Nikon).
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Low-density granulocytes (LDGs) and polymorphonuclear
neutrophils (PMNs) immunophenotyping
Peripheral blood mononuclear cells and PMNs isolated from
psoriasis patients were stained with the following
directly-conjugated monoclonal mouse antihuman anti-
bodies: anti-CD15, CD14, CD11b, CD66b, and CD10 (all
from BioLegend, San Diego, CA); anti-CD62L (eBioscience,
San Diego, CA), anti-fMLPR (Miltenyi Biotec, Bergisch
Gladbach, Germany), or mouse isotype controls. Flow
cytometry was performed on an LSRII (BD Biosciences, San
Jose, CA), and the data were analyzed using the DIVA and
FCS Express software.
ELISA
The levels of NE and SLPI were quantified in lysates of PMNs
and LDGs using direct and sandwich ELISA, respectively. A
total of 2  105 cells were sorted into 50 ml RIPA lysis buffer
(Sigma-Aldrich, Saint Louis, MO). The cell lysates were
collected and stored at e20 C until used.
Measurement of enzymatic activity
A total of 5  104 cells were sorted into 50 ml of 0.1%
hexadecyltrimethylammonium bromide (Sigma-Aldrich) and
incubated at 37 C for 15 minutes. NE activity was assayed in
a colorimetric test using N-methoxysuccinyl-Ala-Ala-Pro-Val
p-nitroanilide, (MeO-SucAAPVpNA) (Sigma-Aldrich) as a
substrate. The absorbance was measured for at least 30 mi-
nutes using a microplate reader (Tecan Infinite M200, Man-
nedorf, Switzerland). The enzyme activity was expressed as
an increase in absorbance at 405 nm per sec (area OD/sec).
Alternatively, NE activity were measured with the fluores-
cence resonance energy transfer substrate, Abz-APEEIMRRQ-
EDDnp, using a microplate reader (Tecan Infinite M200) withexcitation 320 nm and emission 420 nm for 20 minutes at
37 C. The gain value was fixed at 100 for all the experiments
allowing relative fluorescence units comparison.
Preparation of skin extracts
Excisional biopsies were taken from the lesional skin of
psoriasis patients. Skin samples were immediately minced in
RPMI 1640 supplemented with 10% of fetal calf serum at 50
mg skin per 1 ml medium, followed by incubation for 6 hours
at 37 C. Extracts were filtered through a 0.45 mm cell strainer
and stored at e80 C until used.
Chemotaxis assay
Neutrophil populations were tested in an in vitro chemotaxis
assay. A volume of 100 ml of cells (3  105 cells/well) was
added to the top well of 3 mm pore Transwell inserts (Costar,
Sigma-Aldrich, Saint Louis, MO) and chemoattractants, 1 nM
N-formylmethionyl-leucyl-phenylalanine, 50 ng/ml human
CXCL1, skin extracts 1:10 (v:v) were added to the bottom
well in a 600 ml volume. In some experiments, the cells were
preincubated with 20 uM elastase inhibitor GW311616A
(MedChemExpress, Princeton, New Jersey) for 30 minutes.
Migration was assayed for 1.5 hours at 37 C. The inserts
were then removed, and cells that had migrated through the
filter to the lower chamber were collected, stained with anti-
CD15 and CD14 mAbs, and counted by flow cytometry. In
some experiments, the PMNs were first labeled with 62.5 nM
CellTrace Carboxyfluorescein succinimidly ester (Thermo-
Fischer Scientific, Waltham, Massachusetts) for 20 minutes in
phosphate buffered saline. Carboxyfluorescein succinimidly
ester-labeled PMNs were then mixed with autologous PBMCs
at a 1:9 ratio.www.jidonline.org 1378.e1


















mAb, 31, biotin [Abcam] mAb, H36615 [CD] mAb, 20409 [R&D]
**** **


















pAb [Athens Research] pAb [Abcam] mAb, NP57, [DAKO]
** ** **Supplementary Figure S2. Difference
in the NE and SLPI staining pattern
between autologous PMNs and LDGs
is revealed by different NE- and SLPI-
specific Abs. Peripheral blood
mononuclear cells and PMNs were
isolated from blood and stained for
LDGs and PMNs using anti-CD15 and
anti-CD14 mAbs. The expression of
NE or SLPI was evaluated using the
indicated anti-HNE and anti-SLPI Abs




goat antimouse IgG (Abcam,
Cambridge, United Kingdom) and
phycoerythrin-streptavidin
(eBioscience, San Diego, CA or BD
Pharmingen). Each data point
represents one experiment, and bars
indicate the mean value  standard
deviation in each group. **P < 0.01
by a t-test or Mann-Whitney test.





















































Supplementary Figure S1. PMNs with a disrupted actin skeleton resemble
autologous LDGs to some degree in the ability to spontaneously form NETs.
PMNs and PBMCs from healthy donors were treated for 30 minutes with
wiskostatin or lantrunculin A, followed by staining for NE, SLPI, and DNA,
and analysis by fluorescence microscopy. NETs were manually quantified
from 10 randomized high-powered fields per sample and are expressed as the
percentage of total cells. n ¼ 4e6. Each data point represents one experiment,
and bars indicate the mean value  standard deviation in each group.
**P < 0.001 by an analysis of variance followed by a Tukey post hoc test.
FOV, field of view; NET, neutrophil extracellular trap; PBMC, peripheral
blood mononuclear cell; PMN, polymorphonuclear neutrophil.
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Supplementary Figure S3. Chemotactic response of psoriasis blood-derived
neutrophils. PMNs and PBMCs were purified from the blood of psoriasis
patients. The chemotactic responses of the cells to the indicated triggers were
then assayed by in vitro Transwell chemotaxis assay. After 1.5 hours, the input
and migratory cells were stained with anti-CD15 antibodies, to count
neutrophils in either PMNs or PBMCs fraction. n ¼ 10. Each data point
represents one patient. The mean value  standard deviation in each group is
shown. fMLP, N-formylmethionyl-leucyl-phenylalanine; PBMC, peripheral
















































Supplementary Figure S4. NE inhibitor lowers the chemotaxis index in
PMNs and LDGs. PMNs and LDGs (CD15þ PBMCs) were treated with NEi or
vehicle for 30 minutes. Cell migration to the fMLP, CXCL1, psoriasis skin
extracts, or media only was assessed by an in vitro Transwell chemotaxis
assay, n ¼ 4 donors. Data points represent the values of two samples from
each donor. Each data point represents one patient. The mean value 
standard deviation in each group is shown. fMLP, N-formylmethionyl-leucyl-
phenylalanine; LDG, low-density granulocyte; NEi, synthetic inhibitor
GW311616A; PBMC, peripheral blood mononuclear cell; PMN,
polymorphonuclear cell.
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